Pages that link to "Q52116677"
Jump to navigation
Jump to search
The following pages link to A new scale for clinical assessment in geriatric populations: Sandoz Clinical Assessment--Geriatric (SCAG). (Q52116677):
Displaying 50 items.
- Memantine for dementia (Q22252980) (← links)
- Naftidrofuryl for dementia (Q24234540) (← links)
- Ginkgo biloba for cognitive impairment and dementia (Q24241561) (← links)
- Ginkgo biloba for cognitive impairment and dementia (Q24245535) (← links)
- Memantine for dementia (Q24246458) (← links)
- The BEHAVE-AD assessment system: a perspective, a commentary on new findings, and a historical review (Q27022753) (← links)
- Behavioural problems associated with dementia: the role of newer antipsychotics (Q33539480) (← links)
- Pharmacologic management of Alzheimer disease, Part I: Hormonal and emerging investigational drug therapies (Q33543110) (← links)
- Pharmacologic management of Alzheimer disease, Part II: Antioxidants, antihypertensives, and ergoloid derivatives (Q33543113) (← links)
- Memory assessment in studies of cognition-enhancing drugs for Alzheimer's disease (Q33603749) (← links)
- Review of Alzheimer's disease scales: is there a need for a new multi-domain scale for therapy evaluation in medical practice? (Q33675522) (← links)
- Nimodipine for primary degenerative, mixed and vascular dementia (Q33908544) (← links)
- Hydergine for dementia. (Q33908732) (← links)
- Lecithin for dementia and cognitive impairment (Q33908977) (← links)
- Aniracetam (Ro 13-5057) in the treatment of senile dementia of Alzheimer type (SDAT): results of a placebo controlled multicentre clinical study (Q34009629) (← links)
- Piracetam in elderly psychiatric patients with mild diffuse cerebral impairment (Q34259554) (← links)
- Multicentre study of l-alpha-glyceryl-phosphorylcholine vs ST200 among patients with probable senile dementia of Alzheimer's type (Q34363657) (← links)
- Complementary and alternative medical approaches to treating adult neurogenic communication disorders: a review (Q35809579) (← links)
- Methodological problems in assessing therapeutic efficacy in patients with dementia (Q36167899) (← links)
- The Organic Brain Syndrome (OBS) scale: a systematic review (Q36379069) (← links)
- Diagnostic criteria in dementia: a comparison of current criteria, research challenges, and implications for DSM-V. (Q36552889) (← links)
- Brain electrical activity (quantitative EEG and bit-mapping neurocognitive CNV components), psychometrics and clinical findings in presenile subjects with initial mild cognitive decline or probable Alzheimer-type dementia (Q36798487) (← links)
- Therapeutic use of nicergoline (Q37230361) (← links)
- A review of screening instruments for assessing cognition and mental status in older adults. (Q38007212) (← links)
- The dexamethasone suppression test in dementia: a review of the literature (Q38028389) (← links)
- Critical review of clinical trials in senile dementia--II. (Q39173624) (← links)
- Functional Implications of Changes in the Senescent Brain: A Review (Q39237724) (← links)
- Efficacy of antipsychotics in the treatment of the behavioral complications of dementia: a review of the literature (Q39347634) (← links)
- Agitated behaviors in the elderly. I. A conceptual review (Q39743864) (← links)
- Psychologic and Behavioral Assessment of Geriatric Patients: A Review† (Q40062181) (← links)
- Neurotransmitter deficits in Alzheimer's disease: criteria for significance (Q40089993) (← links)
- An ergot alkaloid preparation (Hydergine) in the treatment of dementia: critical review of the clinical literature (Q40776108) (← links)
- Cyclandelate in the Treatment of Senile Mental Changes: A Double-Blind Evaluation (Q40829544) (← links)
- Senile confusion: limitations of assessment by the face-hand test, mental status questionnaire, and staff ratings (Q40874419) (← links)
- Cyclandelate in the Treatment of Senility: A Controlled Study (Q40911661) (← links)
- Methodologic issues regarding outcome measures for clinical drug trials of psychiatric complications in dementia (Q40945378) (← links)
- Electroencephalographic and Clinical Changes as Correlated in Geriatric Patients Treated Three Months with an Ergot Alkaloid Preparation (Q41020759) (← links)
- Efficacy of Nylidrin Hydrochloride in the Treatment of Cognitive Impairment in the Elderly* (Q41020766) (← links)
- Topographic mapping of long latency "cognitive" event-related potentials (P 300): a double-blind, placebo-controlled study with amantadine in mild dementia (Q41095055) (← links)
- Differential effects of single versus combined cognitive and physical training with older adults: the SimA study in a 5-year perspective (Q41278739) (← links)
- Selegiline in treatment of behavioral and cognitive symptoms of Alzheimer disease (Q41317848) (← links)
- Dexamethasone suppression test and response to antidepressant therapy in psychogeriatric patients (Q41440662) (← links)
- The stress of post-disaster body handling and victim identification work (Q42090732) (← links)
- When home care ends--changes in the physical health of informal caregivers caring for dementia patients: a longitudinal study (Q43353518) (← links)
- The development, validation, and applications of a computerized measurement of cognitive impairment from the content analysis of verbal behavior (Q43612239) (← links)
- An exploratory use of the Symptoms Checklist-90 in a mixed geriatric study group (Q43942261) (← links)
- Senile dementia: treatment with deanol (Q43945130) (← links)
- Depot neuroleptics in the treatment of behavioral disorders in patients with Alzheimer's disease (Q44456908) (← links)
- Procedures in evaluating dementia--a study of conjoint application of two rating scales (SCAG and BCRS) and psychometric tests (Q44786805) (← links)
- Senile dementia of the Alzheimer type treated with aniracetam: a new nootropic agent (Q44877013) (← links)